nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.00181	0.00181	CcSEcCtD
Gadoteridol—Syncope—Valsartan—type 2 diabetes mellitus	0.00179	0.00179	CcSEcCtD
Gadoteridol—Dysgeusia—Metformin—type 2 diabetes mellitus	0.00178	0.00178	CcSEcCtD
Gadoteridol—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00178	0.00178	CcSEcCtD
Gadoteridol—Malaise—Orlistat—type 2 diabetes mellitus	0.00178	0.00178	CcSEcCtD
Gadoteridol—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.00177	0.00177	CcSEcCtD
Gadoteridol—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00176	0.00176	CcSEcCtD
Gadoteridol—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.00176	0.00176	CcSEcCtD
Gadoteridol—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00176	0.00176	CcSEcCtD
Gadoteridol—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00175	0.00175	CcSEcCtD
Gadoteridol—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.00175	0.00175	CcSEcCtD
Gadoteridol—Cough—Valsartan—type 2 diabetes mellitus	0.00174	0.00174	CcSEcCtD
Gadoteridol—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00174	0.00174	CcSEcCtD
Gadoteridol—Tinnitus—Losartan—type 2 diabetes mellitus	0.00173	0.00173	CcSEcCtD
Gadoteridol—Cough—Orlistat—type 2 diabetes mellitus	0.00172	0.00172	CcSEcCtD
Gadoteridol—Flushing—Losartan—type 2 diabetes mellitus	0.00172	0.00172	CcSEcCtD
Gadoteridol—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00172	0.00172	CcSEcCtD
Gadoteridol—Erythema—Irbesartan—type 2 diabetes mellitus	0.00171	0.00171	CcSEcCtD
Gadoteridol—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00171	0.00171	CcSEcCtD
Gadoteridol—Convulsion—Orlistat—type 2 diabetes mellitus	0.00171	0.00171	CcSEcCtD
Gadoteridol—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00171	0.00171	CcSEcCtD
Gadoteridol—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00171	0.00171	CcSEcCtD
Gadoteridol—Tremor—Metformin—type 2 diabetes mellitus	0.0017	0.0017	CcSEcCtD
Gadoteridol—Chest pain—Valsartan—type 2 diabetes mellitus	0.0017	0.0017	CcSEcCtD
Gadoteridol—Sweating—Ramipril—type 2 diabetes mellitus	0.0017	0.0017	CcSEcCtD
Gadoteridol—Dizziness—Glipizide—type 2 diabetes mellitus	0.0017	0.0017	CcSEcCtD
Gadoteridol—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00169	0.00169	CcSEcCtD
Gadoteridol—Anxiety—Valsartan—type 2 diabetes mellitus	0.00169	0.00169	CcSEcCtD
Gadoteridol—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.00169	0.00169	CcSEcCtD
Gadoteridol—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00168	0.00168	CcSEcCtD
Gadoteridol—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.00168	0.00168	CcSEcCtD
Gadoteridol—Chest pain—Orlistat—type 2 diabetes mellitus	0.00168	0.00168	CcSEcCtD
Gadoteridol—Anxiety—Orlistat—type 2 diabetes mellitus	0.00167	0.00167	CcSEcCtD
Gadoteridol—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00166	0.00166	CcSEcCtD
Gadoteridol—Discomfort—Orlistat—type 2 diabetes mellitus	0.00166	0.00166	CcSEcCtD
Gadoteridol—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00166	0.00166	CcSEcCtD
Gadoteridol—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00164	0.00164	CcSEcCtD
Gadoteridol—Malaise—Metformin—type 2 diabetes mellitus	0.00164	0.00164	CcSEcCtD
Gadoteridol—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00164	0.00164	CcSEcCtD
Gadoteridol—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Gadoteridol—Vomiting—Glipizide—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Gadoteridol—Syncope—Metformin—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Gadoteridol—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Gadoteridol—Oedema—Valsartan—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Gadoteridol—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Gadoteridol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Gadoteridol—Rash—Glipizide—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Gadoteridol—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Gadoteridol—Erythema—Losartan—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Gadoteridol—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Gadoteridol—Oedema—Orlistat—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Gadoteridol—Headache—Glipizide—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Gadoteridol—Tremor—Irbesartan—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Gadoteridol—Shock—Valsartan—type 2 diabetes mellitus	0.0016	0.0016	CcSEcCtD
Gadoteridol—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.0016	0.0016	CcSEcCtD
Gadoteridol—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00159	0.00159	CcSEcCtD
Gadoteridol—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.00159	0.00159	CcSEcCtD
Gadoteridol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00158	0.00158	CcSEcCtD
Gadoteridol—Dysgeusia—Losartan—type 2 diabetes mellitus	0.00158	0.00158	CcSEcCtD
Gadoteridol—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00158	0.00158	CcSEcCtD
Gadoteridol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00158	0.00158	CcSEcCtD
Gadoteridol—Hypertension—Metformin—type 2 diabetes mellitus	0.00157	0.00157	CcSEcCtD
Gadoteridol—Urticaria—Glyburide—type 2 diabetes mellitus	0.00157	0.00157	CcSEcCtD
Gadoteridol—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00156	0.00156	CcSEcCtD
Gadoteridol—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00156	0.00156	CcSEcCtD
Gadoteridol—Chest pain—Metformin—type 2 diabetes mellitus	0.00155	0.00155	CcSEcCtD
Gadoteridol—Malaise—Irbesartan—type 2 diabetes mellitus	0.00155	0.00155	CcSEcCtD
Gadoteridol—Headache—Pioglitazone—type 2 diabetes mellitus	0.00154	0.00154	CcSEcCtD
Gadoteridol—Syncope—Irbesartan—type 2 diabetes mellitus	0.00154	0.00154	CcSEcCtD
Gadoteridol—Discomfort—Metformin—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Gadoteridol—Nausea—Glipizide—type 2 diabetes mellitus	0.00152	0.00152	CcSEcCtD
Gadoteridol—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00152	0.00152	CcSEcCtD
Gadoteridol—Hypotension—Valsartan—type 2 diabetes mellitus	0.00152	0.00152	CcSEcCtD
Gadoteridol—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00152	0.00152	CcSEcCtD
Gadoteridol—Pain—Gliclazide—type 2 diabetes mellitus	0.00152	0.00152	CcSEcCtD
Gadoteridol—Tremor—Losartan—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Gadoteridol—Rash—Glimepiride—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Gadoteridol—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Gadoteridol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Gadoteridol—Rash—Sitagliptin—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Gadoteridol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Gadoteridol—Headache—Glimepiride—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Gadoteridol—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Gadoteridol—Cough—Irbesartan—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Gadoteridol—Headache—Sitagliptin—type 2 diabetes mellitus	0.00149	0.00149	CcSEcCtD
Gadoteridol—Oedema—Metformin—type 2 diabetes mellitus	0.00148	0.00148	CcSEcCtD
Gadoteridol—Tinnitus—Ramipril—type 2 diabetes mellitus	0.00148	0.00148	CcSEcCtD
Gadoteridol—Hypertension—Irbesartan—type 2 diabetes mellitus	0.00148	0.00148	CcSEcCtD
Gadoteridol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00148	0.00148	CcSEcCtD
Gadoteridol—Flushing—Ramipril—type 2 diabetes mellitus	0.00148	0.00148	CcSEcCtD
Gadoteridol—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Gadoteridol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Gadoteridol—Chest pain—Irbesartan—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Gadoteridol—Shock—Metformin—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Gadoteridol—Malaise—Losartan—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Gadoteridol—Anxiety—Irbesartan—type 2 diabetes mellitus	0.00145	0.00145	CcSEcCtD
Gadoteridol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00145	0.00145	CcSEcCtD
Gadoteridol—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.00145	0.00145	CcSEcCtD
Gadoteridol—Syncope—Losartan—type 2 diabetes mellitus	0.00145	0.00145	CcSEcCtD
Gadoteridol—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00144	0.00144	CcSEcCtD
Gadoteridol—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00144	0.00144	CcSEcCtD
Gadoteridol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Gadoteridol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Gadoteridol—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Gadoteridol—Nausea—Glimepiride—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Gadoteridol—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Gadoteridol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Gadoteridol—Cough—Losartan—type 2 diabetes mellitus	0.00141	0.00141	CcSEcCtD
Gadoteridol—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00141	0.00141	CcSEcCtD
Gadoteridol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.0014	0.0014	CcSEcCtD
Gadoteridol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.0014	0.0014	CcSEcCtD
Gadoteridol—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.0014	0.0014	CcSEcCtD
Gadoteridol—Oedema—Irbesartan—type 2 diabetes mellitus	0.0014	0.0014	CcSEcCtD
Gadoteridol—Pruritus—Glyburide—type 2 diabetes mellitus	0.0014	0.0014	CcSEcCtD
Gadoteridol—Hypotension—Metformin—type 2 diabetes mellitus	0.00139	0.00139	CcSEcCtD
Gadoteridol—Erythema—Ramipril—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Gadoteridol—Shock—Irbesartan—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Gadoteridol—Pain—Orlistat—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Gadoteridol—Chest pain—Losartan—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Gadoteridol—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Gadoteridol—Anxiety—Losartan—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Gadoteridol—Rash—Bromocriptine—type 2 diabetes mellitus	0.00136	0.00136	CcSEcCtD
Gadoteridol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00136	0.00136	CcSEcCtD
Gadoteridol—Discomfort—Losartan—type 2 diabetes mellitus	0.00136	0.00136	CcSEcCtD
Gadoteridol—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.00136	0.00136	CcSEcCtD
Gadoteridol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00135	0.00135	CcSEcCtD
Gadoteridol—Headache—Bromocriptine—type 2 diabetes mellitus	0.00135	0.00135	CcSEcCtD
Gadoteridol—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00135	0.00135	CcSEcCtD
Gadoteridol—Dry mouth—Losartan—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Gadoteridol—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00133	0.00133	CcSEcCtD
Gadoteridol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00133	0.00133	CcSEcCtD
Gadoteridol—Dyspnoea—Metformin—type 2 diabetes mellitus	0.00132	0.00132	CcSEcCtD
Gadoteridol—Oedema—Losartan—type 2 diabetes mellitus	0.00132	0.00132	CcSEcCtD
Gadoteridol—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00132	0.00132	CcSEcCtD
Gadoteridol—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00131	0.00131	CcSEcCtD
Gadoteridol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00131	0.00131	CcSEcCtD
Gadoteridol—Tremor—Ramipril—type 2 diabetes mellitus	0.0013	0.0013	CcSEcCtD
Gadoteridol—Shock—Losartan—type 2 diabetes mellitus	0.0013	0.0013	CcSEcCtD
Gadoteridol—Urticaria—Valsartan—type 2 diabetes mellitus	0.00129	0.00129	CcSEcCtD
Gadoteridol—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00129	0.00129	CcSEcCtD
Gadoteridol—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.00128	0.00128	CcSEcCtD
Gadoteridol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00128	0.00128	CcSEcCtD
Gadoteridol—Urticaria—Orlistat—type 2 diabetes mellitus	0.00128	0.00128	CcSEcCtD
Gadoteridol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Gadoteridol—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Gadoteridol—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Gadoteridol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Gadoteridol—Vomiting—Glyburide—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Gadoteridol—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Gadoteridol—Malaise—Ramipril—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Gadoteridol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Gadoteridol—Rash—Glyburide—type 2 diabetes mellitus	0.00124	0.00124	CcSEcCtD
Gadoteridol—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00124	0.00124	CcSEcCtD
Gadoteridol—Syncope—Ramipril—type 2 diabetes mellitus	0.00124	0.00124	CcSEcCtD
Gadoteridol—Headache—Glyburide—type 2 diabetes mellitus	0.00124	0.00124	CcSEcCtD
Gadoteridol—Hypotension—Losartan—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Gadoteridol—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00122	0.00122	CcSEcCtD
Gadoteridol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.00122	0.00122	CcSEcCtD
Gadoteridol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Gadoteridol—Cough—Ramipril—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Gadoteridol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Gadoteridol—Convulsion—Ramipril—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Gadoteridol—Pain—Irbesartan—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Gadoteridol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00119	0.00119	CcSEcCtD
Gadoteridol—Paraesthesia—Losartan—type 2 diabetes mellitus	0.00118	0.00118	CcSEcCtD
Gadoteridol—Urticaria—Metformin—type 2 diabetes mellitus	0.00118	0.00118	CcSEcCtD
Gadoteridol—Chest pain—Ramipril—type 2 diabetes mellitus	0.00118	0.00118	CcSEcCtD
Gadoteridol—Dyspnoea—Losartan—type 2 diabetes mellitus	0.00117	0.00117	CcSEcCtD
Gadoteridol—Anxiety—Ramipril—type 2 diabetes mellitus	0.00117	0.00117	CcSEcCtD
Gadoteridol—Nausea—Glyburide—type 2 diabetes mellitus	0.00117	0.00117	CcSEcCtD
Gadoteridol—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00117	0.00117	CcSEcCtD
Gadoteridol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00117	0.00117	CcSEcCtD
Gadoteridol—Discomfort—Ramipril—type 2 diabetes mellitus	0.00116	0.00116	CcSEcCtD
Gadoteridol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.00115	0.00115	CcSEcCtD
Gadoteridol—Pruritus—Valsartan—type 2 diabetes mellitus	0.00115	0.00115	CcSEcCtD
Gadoteridol—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00115	0.00115	CcSEcCtD
Gadoteridol—Pruritus—Orlistat—type 2 diabetes mellitus	0.00114	0.00114	CcSEcCtD
Gadoteridol—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00113	0.00113	CcSEcCtD
Gadoteridol—Oedema—Ramipril—type 2 diabetes mellitus	0.00113	0.00113	CcSEcCtD
Gadoteridol—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00113	0.00113	CcSEcCtD
Gadoteridol—Pain—Losartan—type 2 diabetes mellitus	0.00113	0.00113	CcSEcCtD
Gadoteridol—Rash—Gliclazide—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Gadoteridol—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Gadoteridol—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Gadoteridol—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Gadoteridol—Shock—Ramipril—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Gadoteridol—Headache—Gliclazide—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Gadoteridol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Gadoteridol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Gadoteridol—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.0011	0.0011	CcSEcCtD
Gadoteridol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.00109	0.00109	CcSEcCtD
Gadoteridol—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00109	0.00109	CcSEcCtD
Gadoteridol—Dizziness—Valsartan—type 2 diabetes mellitus	0.00108	0.00108	CcSEcCtD
Gadoteridol—Dizziness—Orlistat—type 2 diabetes mellitus	0.00106	0.00106	CcSEcCtD
Gadoteridol—Hypotension—Ramipril—type 2 diabetes mellitus	0.00106	0.00106	CcSEcCtD
Gadoteridol—Nausea—Gliclazide—type 2 diabetes mellitus	0.00105	0.00105	CcSEcCtD
Gadoteridol—Pruritus—Metformin—type 2 diabetes mellitus	0.00105	0.00105	CcSEcCtD
Gadoteridol—Urticaria—Losartan—type 2 diabetes mellitus	0.00105	0.00105	CcSEcCtD
Gadoteridol—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00104	0.00104	CcSEcCtD
Gadoteridol—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00104	0.00104	CcSEcCtD
Gadoteridol—Vomiting—Valsartan—type 2 diabetes mellitus	0.00104	0.00104	CcSEcCtD
Gadoteridol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Gadoteridol—Rash—Valsartan—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Gadoteridol—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Gadoteridol—Vomiting—Orlistat—type 2 diabetes mellitus	0.00102	0.00102	CcSEcCtD
Gadoteridol—Headache—Valsartan—type 2 diabetes mellitus	0.00102	0.00102	CcSEcCtD
Gadoteridol—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Gadoteridol—Rash—Orlistat—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Gadoteridol—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Gadoteridol—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Gadoteridol—Headache—Orlistat—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Gadoteridol—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Gadoteridol—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00099	0.00099	CcSEcCtD
Gadoteridol—Dizziness—Metformin—type 2 diabetes mellitus	0.000981	0.000981	CcSEcCtD
Gadoteridol—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00097	0.00097	CcSEcCtD
Gadoteridol—Nausea—Valsartan—type 2 diabetes mellitus	0.000967	0.000967	CcSEcCtD
Gadoteridol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000958	0.000958	CcSEcCtD
Gadoteridol—Nausea—Orlistat—type 2 diabetes mellitus	0.000956	0.000956	CcSEcCtD
Gadoteridol—Vomiting—Metformin—type 2 diabetes mellitus	0.000943	0.000943	CcSEcCtD
Gadoteridol—Rash—Metformin—type 2 diabetes mellitus	0.000935	0.000935	CcSEcCtD
Gadoteridol—Dermatitis—Metformin—type 2 diabetes mellitus	0.000934	0.000934	CcSEcCtD
Gadoteridol—Pruritus—Losartan—type 2 diabetes mellitus	0.000932	0.000932	CcSEcCtD
Gadoteridol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000931	0.000931	CcSEcCtD
Gadoteridol—Headache—Metformin—type 2 diabetes mellitus	0.000929	0.000929	CcSEcCtD
Gadoteridol—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000925	0.000925	CcSEcCtD
Gadoteridol—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000901	0.000901	CcSEcCtD
Gadoteridol—Urticaria—Ramipril—type 2 diabetes mellitus	0.000897	0.000897	CcSEcCtD
Gadoteridol—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000893	0.000893	CcSEcCtD
Gadoteridol—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000893	0.000893	CcSEcCtD
Gadoteridol—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00089	0.00089	CcSEcCtD
Gadoteridol—Rash—Irbesartan—type 2 diabetes mellitus	0.000882	0.000882	CcSEcCtD
Gadoteridol—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000882	0.000882	CcSEcCtD
Gadoteridol—Nausea—Metformin—type 2 diabetes mellitus	0.000881	0.000881	CcSEcCtD
Gadoteridol—Headache—Irbesartan—type 2 diabetes mellitus	0.000877	0.000877	CcSEcCtD
Gadoteridol—Dizziness—Losartan—type 2 diabetes mellitus	0.000871	0.000871	CcSEcCtD
Gadoteridol—Vomiting—Losartan—type 2 diabetes mellitus	0.000837	0.000837	CcSEcCtD
Gadoteridol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000832	0.000832	CcSEcCtD
Gadoteridol—Nausea—Irbesartan—type 2 diabetes mellitus	0.000831	0.000831	CcSEcCtD
Gadoteridol—Rash—Losartan—type 2 diabetes mellitus	0.00083	0.00083	CcSEcCtD
Gadoteridol—Dermatitis—Losartan—type 2 diabetes mellitus	0.00083	0.00083	CcSEcCtD
Gadoteridol—Headache—Losartan—type 2 diabetes mellitus	0.000825	0.000825	CcSEcCtD
Gadoteridol—Pruritus—Ramipril—type 2 diabetes mellitus	0.000799	0.000799	CcSEcCtD
Gadoteridol—Nausea—Losartan—type 2 diabetes mellitus	0.000782	0.000782	CcSEcCtD
Gadoteridol—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000773	0.000773	CcSEcCtD
Gadoteridol—Dizziness—Ramipril—type 2 diabetes mellitus	0.000747	0.000747	CcSEcCtD
Gadoteridol—Vomiting—Ramipril—type 2 diabetes mellitus	0.000718	0.000718	CcSEcCtD
Gadoteridol—Rash—Ramipril—type 2 diabetes mellitus	0.000712	0.000712	CcSEcCtD
Gadoteridol—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000711	0.000711	CcSEcCtD
Gadoteridol—Headache—Ramipril—type 2 diabetes mellitus	0.000707	0.000707	CcSEcCtD
Gadoteridol—Nausea—Ramipril—type 2 diabetes mellitus	0.000671	0.000671	CcSEcCtD
